BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
May 18, 2011
View Archived Issues
Parasite Study Challenges Old Thinking on Inflammation
Read More
AstraZeneca Declines Option to License BTG's GLP-1 Analogue
Read More
EMA Under Fire from European Parliament
Read More
Angel Investors Sink $3.6M into Stabilitech's Protein Tech
Read More
UK's Biotech, Pharma Groups Continue Collaborative Trend
Read More
Other News To Note
Read More
Clavis, Translational Therapeutics in Antiviral Drug-for-Equity Deal
Clavis Pharma ASA has gained a small equity stake in Translational Therapeutics Inc. in return for out-licensing its modified version of the antiviral drug ribavirin for applications in cancer. (BioWorld International)
Read More
Sanofi Adds Glenmark Antibody to Portfolio for Potential $613M
Read More